Cargando…

SDG indicator 3.b.3 – an analysis of its robustness and challenges for measuring access to medicines for children

BACKGROUND: Sustainable Development Goal (SDG) indicator 3.b.3 monitors progress in medicines’ accessibility for adults and has significant limitations when applying to medicines for children. An adapted indicator methodology was developed to fill this gap, but no proof of its robustness exists. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joosse, I. R., Wirtz, V. J., van Mourik, A. T., Wagner, B. A., Mantel-Teeuwisse, A. K., Suleman, F., van den Ham, H. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239173/ https://www.ncbi.nlm.nih.gov/pubmed/37270535 http://dx.doi.org/10.1186/s12913-023-09554-w

Ejemplares similares

Missing data on accessibility of children’s medicines
por: Joosse, Iris R, et al.
Publicado: (2022)

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study
por: Joosse, Iris R, et al.
Publicado: (2023)

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2021)

Evidence on the effectiveness of policies promoting price transparency - A systematic review
por: Joosse, Iris R., et al.
Publicado: (2023)

Healthcare workers’ perspectives on access to sexual and reproductive health services in the public, private and private not-for-profit sectors: insights from Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2022)

COVID-19 pandemic: The fears and hopes for SDG 3, with focus on prevention and control of noncommunicable diseases (SDG 3.4) and universal health coverage (SDG 3.8)
por: Takian, Amirhossein, et al.
Publicado: (2022)

Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia
por: Ooms, Gaby I., et al.
Publicado: (2020)

Identification of urban land use efficiency by indicator-SDG 11.3.1
por: Cai, Guoyin, et al.
Publicado: (2020)

Understanding health spending for SDG 3
por: Sundewall, Jesper, et al.
Publicado: (2020)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Accelerating the SDG3 Global Action Plan
por: Voss, Maike, et al.
Publicado: (2019)

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019
por: Kusynová, Zuzana, et al.
Publicado: (2022)

Sustainable Development Goal for Quality Education (SDG 4): A study on SDG 4 to extract the pattern of association among the indicators of SDG 4 employing a genetic algorithm
por: Saini, Munish, et al.
Publicado: (2022)

How healthy is a ‘healthy economy’? Incompatibility between current pathways towards SDG3 and SDG8
por: Meurs, Mariska, et al.
Publicado: (2019)

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018
por: Kibira, Denis, et al.
Publicado: (2021)

Strengthen health systems to achieve the SDG targets for healthy children: Evidence on access to medicines situation in Nepal
por: Sharma, Abhishek, et al.
Publicado: (2022)

Mutational Robustness of Gene Regulatory Networks
por: van Dijk, Aalt D. J., et al.
Publicado: (2012)

Linking market authorizations of medicines with disease burden in South Africa
por: Narsai, K., et al.
Publicado: (2021)

Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review
por: Jacobs, Tom G., et al.
Publicado: (2019)

Structural basis for SdgB- and SdgA-mediated glycosylation of staphylococcal adhesive proteins
por: Kim, Dong-Gyun, et al.
Publicado: (2021)

The role of context in identifying linkages between SDG 2 (food) and SDG 6 (water)
por: Su, Han, et al.
Publicado: (2022)

Donor Commitments and Disbursements for Sexual and Reproductive Health Aid in Kenya, Tanzania, Uganda and Zambia
por: Kibira, Denis, et al.
Publicado: (2021)

Iran to achieve the SDG 3.4 at national and sub-national levels
por: Haghdoost, Ali Akbar, et al.
Publicado: (2022)

The politics of national SDG indicator systems: A comparison of four European countries
por: Lepenies, Robert, et al.
Publicado: (2023)

8.F. Workshop: SDG indicators: country scenarios and the way towards 2030
Publicado: (2023)

Summary of SDG Discussion Session
por: Paul, Ayan
Publicado: (2022)

Nowcasting and monitoring SDG 8
por: Bilek-Steindl, Sandra, et al.
Publicado: (2022)

SDG3-related inequalities in women’s, children’s and adolescents’ health: an SDG monitoring baseline for Latin America and the Caribbean using national cross-sectional surveys
por: Sanhueza, Antonio, et al.
Publicado: (2021)

Histone methyltransferases SDG33 and SDG34 regulate organ-specific nitrogen responses in tomato
por: Bvindi, Carol, et al.
Publicado: (2022)

A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya
por: Perehudoff, Katrina, et al.
Publicado: (2022)

Beyond COVID-19: Applying “SDG logics” for resilient transformations
por: van Zanten, Jan Anton, et al.
Publicado: (2020)

Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya
por: Ooms, Gaby Isabelle, et al.
Publicado: (2021)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030
por: Martelletti, Paolo, et al.
Publicado: (2023)

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023)

European collaborations on medicine and vaccine procurement
por: Vogler, Sabine, et al.
Publicado: (2021)

Crowd4SDG Final Conference
por: Parodi, Carole
Publicado: (2023)

Mapping Collaborations and Partnerships in SDG Research
por: Payumo, Jane, et al.
Publicado: (2021)

National medicines policies – a review of the evolution and development processes
por: Hoebert, Joëlle M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7rvqtm0gfajkpp0hu2ejpupjir